摘要:
The present invention relates to an aqueous pharmaceutical composition for a sustained release of a LHRH analogue, in particular for a sustained release compatible with therapeutic treatments for at least 2 weeks. The pharmaceutical compositions are particularly useful for the treatment of diseases a LHRH analogue is indicated for.
摘要:
The present invention relates to ready-to-use liquid or semi-solid pharmaceutical compositions, containing natural mineral clays as active ingredient. These compositions are particularly useful for the treatment of acute and chronic diarrhoea.
摘要:
The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays. These compositions are particularly useful for the treatment of acute and chronic diarrhoea.
摘要:
The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays. These compositions are particularly useful for the treatment of acute and chronic diarrhoea.
摘要:
The present invention relates to new phenylic derivatives, wherein these products exhibit a good affinity for certain sub-types of cannabinoid receptors, in particular the CB2 receptors. They are of particular interest for treating pathological conditions and diseases in which one or more cannabinoid receptors are involved. The invention also relates to pharmaceutical compositions containing said products, and to the use thereof for the preparation of a drug.
摘要:
The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium.